Brief: Imunon Announces Positive Cmc Meeting With FDA For Imnn-001 In Treatment Of Advanced Ovarian Cancer

Imunon

19/12/2024 14:12

Dec 19 (Reuters) - Imunon Inc  IMNN.O :
    * IMUNON ANNOUNCES POSITIVE CMC MEETING WITH FDA FOR
IMNN-001 IN
TREATMENT OF ADVANCED OVARIAN CANCER
    * ALIGNS WITH FDA ON CMC STRATEGY FOR PHASE 3 TRIAL
    * ON TRACK TO INITIATE PHASE 3 PIVOTAL TRIAL OF IMNN-001 IN
Q1 OF
2025
    * TO INITIATE PHASE 3 TRIAL OF IMNN-001 IN Q1 2025

Source text:  ID:nGNX3ysqBm 
Further company coverage:  IMNN.O 

 ((Reuters.Briefs@thomsonreuters.com;))